在固体瘤中抗体-药物结合物的生物标志物
Jalissa Katrini1,2, Laura Boldrini1,2, Celeste Santoro1,2
1Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.
Molecular cancer therapeutics
|February 16, 2024
概括
抗体-药物合物 (ADCs) 正通过向癌细胞来彻底改变癌症治疗. 虽然ADC并不总是需要完美的抗原匹配,但在各种瘤中显示出有希望的疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗体-药物合物 (ADC) 代表了癌症治疗的重大进步,提供了针对性地传递细胞毒性有效载荷.
- 抗癌药物在不同类型的瘤中表现出异质的临床疗效和安全性.
- 抗毒剂的开发与精准医学的原则保持一致,旨在实现高效率与降低毒性.
研究的目的:
- 审查目前在临床实践中批准的抗体-药物联合体 (ADC) 的现状.
- 分析ADC与癌症抗原表达水平相关的临床活性.
- 阐明影响ADC安全性和有效性的关键决定因素,包括它们在顺序治疗中的使用.
主要方法:
- 关于已批准的抗体-药物合物的现有文献和临床数据的全面审查.
- 分析报告的与瘤抗原表达相关的疗效和安全数据.
- 探索影响ADC性能的因素,包括低或异质抗原表达的瘤中的活性潜力.
主要成果:
- ADCs已经改变了某些癌症的治疗方法,改善了生存率和生活质量.
- 临床疗效各不相同,一些ADC受益于生物标志物选择的种群,而另一些则表现出超出严格目标匹配的活性.
- 瘤抗原表达水平是关键因素,但其他决定因素也影响ADC的安全性和有效性.
结论:
- 现代ADC甚至在异质或低抗原表达的瘤中提供潜在的治疗益处,挑战了传统的"完美匹配"范式.
- 了解ADC安全性和有效性的决定因素对于优化其临床应用至关重要.
- 抗癌药物是现代瘤学的基石,目前正在进行的研究正在扩大它们的实用性和完善治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.